- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01505023
Partial Meal Replacement and Inulin in Obese Women
January 4, 2012 updated by: SANDRA GARCiA PADILLA, Cindetec
Evaluation of the Effectiveness of a Partial Meal Replacement With Inulin on Obesity and Dyslipidemias in Women.
The objective of this study was to test the efficacy of a partial meal replacement added with vitamins, minerals and inulin on weight reduction, blood lipids and micronutrients intake in obese Mexican women
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
179
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Querétaro, Mexico, 76230
- Universidad Autonoma de Queretaro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- BMI > 25 kg/m 2
Exclusion Criteria:
- Pregnant
- Lactating
- Diagnosed with diabetes
- Diagnosed with hypertension
- Fasting glucose ≥126 mg/dL
- Blood triglycerides ≥400mg/dL
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No intervention
|
|
|
Active Comparator: Partial meal replacement
|
The PMR was designed to contain sufficient amounts of all vitamins and minerals.
Women were instructed to consume 2 servings per day at breakfast and dinner, each consisting of 33 g of powder dissolved in 250 ml of skim milk.
|
|
Experimental: Partial meal replacement with inulin
|
The PMR was designed to contain sufficient amounts of all vitamins and minerals plus inulin.
Women were instructed to consume 2 servings per day at breakfast and dinner, each consisting of 33 g of powder dissolved in 250 ml of skim milk.
|
|
Active Comparator: Inulin
|
Women were asked to consume one 5g serving of inulin mixed with any drink at breakfast and same amount at dinner (10 g of inulin/d).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Weight
|
|
Blood lipids
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Micronutrients intake
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2006
Primary Completion (Actual)
November 1, 2006
Study Completion (Actual)
February 1, 2007
Study Registration Dates
First Submitted
January 4, 2012
First Submitted That Met QC Criteria
January 4, 2012
First Posted (Estimate)
January 6, 2012
Study Record Updates
Last Update Posted (Estimate)
January 6, 2012
Last Update Submitted That Met QC Criteria
January 4, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEE-001-2004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.